| Literature DB >> 32070033 |
Federica Palombarini1, Elisa Di Fabio1, Alberto Boffi1, Alberto Macone1, Alessandra Bonamore1.
Abstract
The delivery of therapeutic proteins is one of the greatest challenges in the treatment of human diseases. In this frame, ferritins occupy a very special place. Thanks to their hollow spherical structure, they are used as modular nanocages for the delivery of anticancer drugs. More recently, the possibility of encapsulating even small proteins with enzymatic or cytotoxic activity is emerging. Among all ferritins, particular interest is paid to the Archaeoglobus fulgidus one, due to its peculiar ability to associate/dissociate in physiological conditions. This protein has also been engineered to allow recognition of human receptors and used in vitro for the delivery of cytotoxic proteins with extremely promising results.Entities:
Keywords: Archaeoglobus fulgidus; TfR1 receptor; drug delivery; ferritin; nanocarrier; therapeutic proteins; tumor cells
Year: 2020 PMID: 32070033 DOI: 10.3390/molecules25040825
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411